Patents by Inventor Sara Cherry

Sara Cherry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230144186
    Abstract: The invention provides methods and compositions for assaying infectivity of viruses and potential treatments of such viruses in the upper respiratory tract using an air-liquid interface model with nasal epithelium cells; and treatment of viral infections of the upper respiratory tract by treating with bitter taste receptor agonists that stimulate NO production and/or antimicrobial protein production.
    Type: Application
    Filed: April 21, 2021
    Publication date: May 11, 2023
    Inventors: Noam Cohen, Robert J. Lee, Susan R. Weiss, Joel N. Maslow, Christine C. Roberts, Sara Cherry, Michael Kohanski, Nithin D. Adappa, James N. Palmer, Li Hui Tan
  • Publication number: 20210260144
    Abstract: The invention provides methods and compositions for assaying infectivity of viruses and potential treatments of such viruses in the upper respiratory tract using an air-liquid interface model with nasal epithelium cells; and treatment of viral infections of the upper respiratory tract by treating with bitter taste receptor agonists that stimulate NO production and/or antimicrobial protein production.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 26, 2021
    Applicants: The Trustees of the University of Pennsylvania, Monell Chemical Senses Center, GeneOne Life Science, Inc.
    Inventors: Noam A. Cohen, Robert J. Lee, Susan R. Weiss, Joel N. Maslow, Christine C. Roberts, Sara Cherry, Michael Kohanski, Nithin D. Adappa, James N. Palmer, Li Hui Tan
  • Publication number: 20130295115
    Abstract: Provided herein are compositions and methods for treating a disease or disorder associated with an alphavirus infection. Specifically, the invention relates to administering a Natural Resistance-Associated Macrophage Protein (NRAMP) antagonist to prevent binding or infection of an alphavirus to its host.
    Type: Application
    Filed: November 16, 2011
    Publication date: November 7, 2013
    Inventors: Sara Cherry, Patrick Rose